Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma

Australian and New Zealand Journal of Surgery

Volumn 70, Issue 1, 2000, Pages 26-33

  Lord, Reginald V N ^a   Frommer, Donald J ^a   Inder, Stephanie ^a   Tran, Dinh ^a   Ward, Robyn L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Gastro oesophageal reflux disease; Helicobacter pylori; Oesophageal adenocarcinoma; Oesophagitis; Oesophagus

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PREVALENCE;

EID: 0033960557     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2000.01737.x     Document Type: Article

References (61)

1. Lord RV, Law MG, Ward RL, Giles GG, Thomas RJ, Thursfield V. Rising incidence of oesophageal adenocarcinoma in men in Australia. J. Gastroenierol. Hepaiol. 1998; 13: 356-62.
2. Thomas RJ, Lade S, Giles GG, Thursfield V. Incidence trends in oesqphageal and proximal gastric carcinoma in Victoria. Aust. N.Z. J.Surg. 1996; 66: 271-5.
3. Devesa SS, Blot WJ, Fraumeni Jr JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
4. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologie spectrum of Barren's esophagus. N. Engl. J. Mcd. 1976;295:476-80.
5. Skinner DB, Walther BC, Riddell RH, Schmidt H, lascone C, Demeester TR. Barren's esophagus. Comparison of benign and malignant cases. Ann. Surg. 1983; 198: 554-65.
6. Reid BJ. Barren's esophagus and esophageal adenocarcinoma. Gastroenierol. Clin. North Am. 1991; 20: 817-34.
7. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Hclicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophaaitis. Gastroenterology 1997; 112: 1442-7.
8. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig. Dis. Sci. 1997; 42: 103-5.
9. Sacca N, De Medici A, Rodino S, De Siena M, Giglio A. Reflux esophagitis: A complication of Helicobacter pylori eradication therapy? [Letter] Endoscopy 1997; 29: 224.
10. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am. J. Gastroenierol. 1999; 94: 884-7.
11. Loffeld RJ, Werdmuller BF, Kusters JG, Perez-Perez GI, Blaser MJ, Kuipers EJ. cag-A+ H. pylori infection protects against GERD. Gastroenterology 1999; 116: G1038.
12. Wu JC, Sung JJ, Ng EK et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the Eastern. J. Gastroenterol. 1999; 94: 1790-4.
13. Quddus MR, Henley JD, Sulaiman RA, Palumbo TC, Gnepp DR. Helicobacter pylori infection and adenocarcinoma arising in Barren's esophagus. Hum. Palhol. 1997; 28: 1007-9.
14. Chow WH, Blaser MJ, Blot WJ et eil. An inverse relation between cagA+ strains of Helicobacier pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998; 58: 588-90.
15. Vicari JJ, Peek RM, Falk GW et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-7.
16. Prach AT, Macdonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barren's oesophagus: Education, enthusiasm, or epidemiology? [Letter] Lancet 1997; 350: 933.
17. Blaser MJ. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease. J. Infect. Dis. 1999; 179: 1523-30.
18. Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am. J. Gastroenterol. 1998; 93: 1800-2.
19. Csendes A, Smok G, Cerda G, Burdiles P, Mazza D, Csendes P. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barren's esophagus. Dis. Esopli. 1997; 10: 38-42.
20. Talley NJ, Janssens J, Lauritsen K. No increase of reflux symptoms or eosphagitis in patients treated with non-ulcer dyspepsia 12'months after Helicobacter pylori eradication. A randomised double-blind placebo-controlled trial. Gastroenterology 1998; 114: A306.
21. Malfertheiner P, Veldhuyzen van Zanten S, Dent J. Does cure of Helicobacter pylori infection induce heartburn? Gastroenterology 1998; 114: A2392.
22. Blaser MJ, Perez-Perez GI, Lindenbaum J et al. Association of infection due to Helicobacier pylori with specific upper gastrointestinal pathology. Rev. Infect. Dis. 1991; 13 (Suppl. 8): S704-8.
23. Houck JA, Lucas JG. Absence of Campylobacter-liks organisms in Barren's esophagus. Arch. Pathol. Lab. Meil. 1989; 113:470-2.
24. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Cainpylobacter pylori and Barren's esophagus. Mayo Clin. Proc. 1988; 63: 1176-80.
25. Walker SJ, Birch PJ, Stewart M, Stoddard CJ, Hart CA, Day DW. Patterns of colonisation of Cainpylobacter pylori in the oesophagus, stomach and duodenum. Gut 1989; 30: 1334-48.
26. Lewin KJ, Appelman HD. Barren's esophagus, columnar dysplasia, and adenocarcinoma of the esophagus. In: Lewin KJ, Appelman HD (eds) Tumors of the Esophagus and Stomach. Washington DC: Armed Forces Institute of Pathology, 1996; 99-144.
27. Hamilton SR. Adenocarcinoma in Barren's oesophagus. In: Whitehead R (ed.) Gastrointestinal and Oesophageal Pathology. Edinburgh: Churchill Livingstone, 1989; 683-700.
28. Oberg S, Peters JH, Demeester TR etal. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann. Surg. 1997; 226: 522-30.
29. Field AS, Marriott DJ, Hing MC. The Warthin-Starry stain in the diagnosis of small intestinal microsporidiosis in HIV-infected patients. Folia Parasitai. (Pralia) 1993; 40: 261-6.
30. Goodwin CS, Armstrong JA, Marshall BJ. Cainpylobacter pyloridis, gastritis, and peptic ulceration. J. Clin. Pathol. 1986; 39: 353-65.
31. Steer HW. Surface morphology of the gastroduodenal mucosa in duodenal ulcération. Gut 1984; 25: 1203-10.
32. Kames WEJ, Samloff IM, Siurala M et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophie body gastritis. Gastroenterology 1991; 101: 167-74.
33. Genta RM, Graham DY. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scaiul. J. Gastroenterol. 1993; 28: 924-8.
34. Hackelsbcrger A, Gunther T, Schultze V et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998; 43: 17-21.
35. Chen YY, Antonioli DA, Spechler Si, Zeroogian JM, Goyal RK, Wang HH. Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis. Mod. Patlwl. 1998; 11: 950-6.
36. Goldblum JR, Vicari JJ, Falk GW et al. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998; 114: 633-9.
37. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum. Palhol. 1994; 25: 915-19.
38. Fallingborg J, Agnholt J, Moller-Petersen J et al. Campylobacter pylori m esophagus [Letter]. Dig. Dis. Sci. 1989; 34: 1802-3.
39. Lin SK, Lambert JR, Nicholson L, Lukito W, Wahlqvist M. Prevalence of Helicobacter pylori in a representative AngloCeltic population of urban Melbourne. J. Gastroenterol. Hepatol. 1998; 13: 505-10.
40. Marshall BJ. The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA 1995; 274: 1064-6.
41. EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-6.
42. Parsonnet J. Helicobacter pylori: The size of the problem. Gut 1998;43(SuppI. 1): S6-9.
43. Talley R, Weinstein WM, Marin-Sorensen M, Schneidman D, Reedy TJ, Van Deventer G. Campylobacter pylori colonisation of Barren's esophagus. Gastroenterology 1988; 94: A454.
44. Hazell SL, Carrick J, Lee A. Campylobacter pylori can infect the oesophagus when gastric tissue is'present. Gastroenterology 1988; 94: A178.
45. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barren's esophagus. Gastroenterology 1988; 95: 216-18.
46. Kalogeropoulos NK, Whitehead R. Cainpylobacter-like organisms and Candida in peptic ulcers and similar lesions of the upper gastrointestinal tract: A study of 247 cases. J. Clin. Palhol. 1988; 41: 1093-8.
47. Francoual S, Lamy P, Le Quintrec Y, Luboinski J, Petit JC. Helicobacter pylori: Has it a part in the lesion of the gastroesophageal reflux? [Letter] J. Infect. Dis. 1990; 162: 1414-15.
48. Gruppo Operativo per lo Studio Delle Precancerosi Esofagee (GOSPE; Precancerous Lesions of the Oesophagus Task Force, Italy). Helicobacter pylori in Barren's oesophagus. Histopathology 1991; 18: 568-70.
49. Ferreres J-C, Fernandez F, Rodriguez VA et al. Helicobacter pylori in Barren's esophagus. Histol. Histopathol. 1991; 6: 403-8.
50. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barren's esophagus. Am.J. Gastroenterol. 1992; 87: 1598-600.
51. Justin TA, Steele RJC. Helicobacter infection is associated with oesophasitis in patients with Barren's oesophagus. Gut 1994; 35: A5.
52. Abbas Z, Hussainy AS, Ibrahim F, Jafri SM, Shaikh H, Khan AH. Barren's oesophagus and Helicobacter pylori. J. Gastroenterol. Hepatol. 1995; 10: 331-3.
53. Ricaurte O, Flejou JF, Vissuzaine C et al. Helicobacter pylori infection in patients with Barren's oesophagus: A prospective immunohistochemical study. J. Clin. Patlwl. 1996; 49: 176-7.
54. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux oesophagitis and Barren's oesophagus. Gut 1997; 40: 9-13.
55. Wright TA, Myskow M, Kingsnorth AN. Helicobacter pylori colonization of Barren's esophagus and its progression to cancer. Dis. Esopli. 1997; 10: 196-200.
56. Henihan RD, Stuart RC, Nolan N, Gorey TF, Hennessy TP, O'Morain CA. Barren's esophagus and the presence of Helicobacter pylori. Am. J. Gastroenterol. 1998; 93: 542-6.
57. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter. pylori infection. Gut 1997; 40: 297-301.
58. Blaser MJ, Perez-Perez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995; 55: 2111-15.
59. Queiroz DM, Mendes EN, Rocha GA et al. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int. J. Cancer 1998; 78: 135-9.
60. Prophet EB, Mills B, Arrington JB, Sobin LH. Armed Forces Institute of Pathology Laboratory Methods in Histotechnology. Washington DC: American Registry of Pathology, 1992; 214.
61. Field AS, Hing MC, Milliken ST, Marriott DJ. Microsporidia in the small intestine of HIV-infected patients. A new diagnostic technique and a new species. Med. J. Anst. 1993; 158: 390-4.